These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28401525)

  • 1. New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca.
    McKenna D; Riba J
    Curr Top Behav Neurosci; 2018; 36():283-311. PubMed ID: 28401525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca.
    McKenna D; Riba J
    Curr Top Behav Neurosci; 2015 Feb; ():. PubMed ID: 25655746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic psychedelics temporarily modify information transfer in humans.
    Alonso JF; Romero S; Mañanas MÀ; Riba J
    Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25820842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subacute effects of the psychedelic ayahuasca on the salience and default mode networks.
    Pasquini L; Palhano-Fontes F; Araujo DB
    J Psychopharmacol; 2020 Jun; 34(6):623-635. PubMed ID: 32255395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.
    Sampedro F; de la Fuente Revenga M; Valle M; Roberto N; Domínguez-Clavé E; Elices M; Luna LE; Crippa JAS; Hallak JEC; de Araujo DB; Friedlander P; Barker SA; Álvarez E; Soler J; Pascual JC; Feilding A; Riba J
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):698-711. PubMed ID: 28525587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca.
    Viol A; Palhano-Fontes F; Onias H; de Araujo DB; Viswanathan GM
    Sci Rep; 2017 Aug; 7(1):7388. PubMed ID: 28785066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hallucinogenic world of tryptamines: an updated review.
    Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
    Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.
    Riba J; Romero S; Grasa E; Mena E; Carrió I; Barbanoj MJ
    Psychopharmacology (Berl); 2006 May; 186(1):93-8. PubMed ID: 16575552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.
    Riga MS; Soria G; Tudela R; Artigas F; Celada P
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1269-82. PubMed ID: 24650558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
    McKenna DJ; Towers GH; Abbott F
    J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease.
    Katchborian-Neto A; Santos MFC; Vilas-Boas DF; Dos Santos EG; Veloso MP; Bueno PCP; Caldas IS; Soares MG; Dias DF; Chagas-Paula DA
    Chem Biodivers; 2022 Oct; 19(10):e202200409. PubMed ID: 36163588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.
    Bouso JC; Palhano-Fontes F; Rodríguez-Fornells A; Ribeiro S; Sanches R; Crippa JA; Hallak JE; de Araujo DB; Riba J
    Eur Neuropsychopharmacol; 2015 Apr; 25(4):483-92. PubMed ID: 25637267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the Psychoactive Effects of Ayahuasca: Cultural and Pharmacological Relevance of Its Emetic and Purging Properties.
    Politi M; Tresca G; Menghini L; Ferrante C
    Planta Med; 2022 Nov; 88(14):1275-1286. PubMed ID: 34794194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
    Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of Tryptamines and β-Carbolines in Ayahuasca Beverage Consumed During Brazilian Religious Ceremonies.
    Santos MC; Navickiene S; Gaujac A
    J AOAC Int; 2017 May; 100(3):820-824. PubMed ID: 28105971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
    Hamill J; Hallak J; Dursun SM; Baker G
    Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.
    Riba J; Anderer P; Jané F; Saletu B; Barbanoj MJ
    Neuropsychobiology; 2004; 50(1):89-101. PubMed ID: 15179026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indigenous healing practice: ayahuasca. Opening a discussion.
    Prue R; Voss RW
    J Pastoral Care Counsel; 2014; 68(1-2):6. PubMed ID: 25241484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in spirituality among ayahuasca ceremony novice participants.
    Trichter S; Klimo J; Krippner S
    J Psychoactive Drugs; 2009 Jun; 41(2):121-34. PubMed ID: 19705674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
    Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
    J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.